Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Briana Cameron

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Statistical Methods in Medical Research|November 23, 2016
Sample size and power for a stratified doubly randomized preference designBriana Cameron, Denise A Esserman
Pharmaceutical Statistics|December 20, 2018
On weighted composite scores for early Alzheimer's trialsKun Jin, Briana Cameron, Billy Dunn
Statistics in Medicine|June 2, 2018
Extensions to the two-stage randomized trial design for testing treatment, self-selection, and treatment preference effects to binary outcomesBriana Cameron, Peter Peduzzi, Denise Esserman
Public Health Nutrition|June 30, 2020
Demographic, spatial and temporal dietary intake patterns among 526 774 23andMe research participantsJanie F Shelton, Briana Cameron, Stella Aslibekyan, et al.
Ophthalmology. Retina|April 15, 2022
Prevalence and Progression of Macular Atrophy in Eyes with Neovascular Age-Related Macular Degeneration in the Phase 2 Ladder Trial of the Port Delivery System with RanibizumabGlenn J Jaffe, Briana Cameron, David Kardatzke, et al.
Statistics in Medicine|September 3, 2020
Two-stage randomized trial design for testing treatment, preference, and self-selection effects for count outcomesYu Shi, Briana Cameron, Xian Gu, et al.
Ophthalmology. Retina|February 27, 2025
Macular Atrophy-Related Observations in Eyes Treated with the Port Delivery System with Ranibizumab in the Archway TrialGlenn J Jaffe, Briana Cameron, Giulio Barteselli, et al.
Journal of Asthma and Allergy|September 23, 2024
Does Comorbid Food Allergy Affect Response to Omalizumab in Patients with Asthma?Alessandro Fiocchi, R Sharon Chinthrajah, Ignacio J Ansotegui, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2026
Longitudinal magnetic resonance spectroscopy study of metabolite changes over 2 years in relapsing and primary progressive multiple sclerosis treated with ocrelizumabErin L MacMillan, Bretta Russell-Schulz, Glaynel Alejo, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2023
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activityKoji Shinoda, Rui Li, Ayman Rezk, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Statistical Methods in Medical Research|November 23, 2016
Sample size and power for a stratified doubly randomized preference designBriana Cameron, Denise A Esserman
Pharmaceutical Statistics|December 20, 2018
On weighted composite scores for early Alzheimer's trialsKun Jin, Briana Cameron, Billy Dunn
Statistics in Medicine|June 2, 2018
Extensions to the two-stage randomized trial design for testing treatment, self-selection, and treatment preference effects to binary outcomesBriana Cameron, Peter Peduzzi, Denise Esserman
Public Health Nutrition|June 30, 2020
Demographic, spatial and temporal dietary intake patterns among 526 774 23andMe research participantsJanie F Shelton, Briana Cameron, Stella Aslibekyan, et al.
Ophthalmology. Retina|April 15, 2022
Prevalence and Progression of Macular Atrophy in Eyes with Neovascular Age-Related Macular Degeneration in the Phase 2 Ladder Trial of the Port Delivery System with RanibizumabGlenn J Jaffe, Briana Cameron, David Kardatzke, et al.
Statistics in Medicine|September 3, 2020
Two-stage randomized trial design for testing treatment, preference, and self-selection effects for count outcomesYu Shi, Briana Cameron, Xian Gu, et al.
Ophthalmology. Retina|February 27, 2025
Macular Atrophy-Related Observations in Eyes Treated with the Port Delivery System with Ranibizumab in the Archway TrialGlenn J Jaffe, Briana Cameron, Giulio Barteselli, et al.
Journal of Asthma and Allergy|September 23, 2024
Does Comorbid Food Allergy Affect Response to Omalizumab in Patients with Asthma?Alessandro Fiocchi, R Sharon Chinthrajah, Ignacio J Ansotegui, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2026
Longitudinal magnetic resonance spectroscopy study of metabolite changes over 2 years in relapsing and primary progressive multiple sclerosis treated with ocrelizumabErin L MacMillan, Bretta Russell-Schulz, Glaynel Alejo, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2023
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activityKoji Shinoda, Rui Li, Ayman Rezk, et al.
Pageof 2